Premium
O3‐10‐05: MODULATION OF MICRORNA PATHWAYS BY GEMFIBROZIL IN PREDEMENTIA ALZHEIMER DISEASE: A RANDOMIZED, PLACEBO‐CONTROLLED, DOUBLE‐BLIND CLINICAL TRIAL
Author(s) -
Jicha Gregory A.,
Kryscio Richard J.,
Beech Brooke F.,
Wang Wang-Xia,
Lynn Bert C.,
Schmitt Frederick A.,
Coy Beth,
Al-Janabi Omar M.,
Abner Erin L.,
Nelson Peter T.
Publication year - 2019
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2019.06.4682
Subject(s) - gemfibrozil , placebo , medicine , adverse effect , population , clinical trial , randomized controlled trial , endocrinology , pharmacology , pathology , cholesterol , environmental health , alternative medicine
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom